Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-04-04
2006-04-04
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S226800, C514S227800, C514S236200, C514S254020, C514S256000, C514S269000, C544S055000, C544S060000, C544S096000, C544S112000, C544S113000, C544S238000, C544S242000, C544S367000
Reexamination Certificate
active
07022705
ABSTRACT:
Compounds of the formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof,wherein, for example,HET is an N-linked 5-membered, fully or partially unsaturated heterocyclic ring, orHET is an N-linked 6-membered di-hydro-heteroaryl ring;Q is, for example, Q1 or Q2:wherein R2and R3are independently hydrogen or fluoro;T is selected from a range of groups, for example a group of the formula (TC7)wherein Rc is, for example, hydrogen, R13CO—, R13SO2— or R13CS—;wherein R13is, for example, optionally substituted (1–10C)alkyl or R14C(O)O(1–6C)alkylwherein R14is optionally substituted (1–10C)alkyl; are useful as antibacterial agents; andprocesses for their manufacture and pharmaceutical compositions containing them are described.
REFERENCES:
patent: 3318878 (1967-05-01), Dunn
patent: 3769295 (1973-10-01), Hoyle
patent: 5156669 (1992-10-01), Zierke et al.
patent: 199 09 785 (2000-09-01), None
patent: 199 62 924 (2001-07-01), None
patent: 0 455 052 (1991-11-01), None
patent: 1 227 084 (2002-07-01), None
patent: WO-93/23384 (1993-11-01), None
patent: WO-97/14690 (1997-04-01), None
patent: WO-97/23212 (1997-07-01), None
patent: WO-97/27188 (1997-07-01), None
patent: WO-97/30995 (1997-08-01), None
patent: WO-97/31917 (1997-09-01), None
patent: WO-97/43280 (1997-11-01), None
patent: WO-98/01446 (1998-01-01), None
patent: WO-98/01447 (1998-01-01), None
patent: WO-98/07708 (1998-02-01), None
patent: WO-98/15541 (1998-04-01), None
patent: WO-98/57937 (1998-12-01), None
patent: WO-99/10343 (1999-03-01), None
patent: WO-99/11642 (1999-03-01), None
patent: WO-99/10342 (1999-04-01), None
patent: WO-99/28317 (1999-06-01), None
patent: WO-99/41244 (1999-08-01), None
patent: WO-99/43671 (1999-09-01), None
patent: WO-99/64416 (1999-12-01), None
patent: WO-99/64417 (1999-12-01), None
patent: WO-00/10566 (2000-03-01), None
patent: WO-00/21960 (2000-04-01), None
patent: WO-00/41473 (2000-07-01), None
patent: WO-01/07422 (2001-02-01), None
patent: WO-01/26656 (2001-04-01), None
patent: WO-01/40222 (2001-06-01), None
patent: WO-01/40236 (2001-06-01), None
patent: WO-02/081468 (2001-06-01), None
patent: WO-01/81350 (2001-11-01), None
patent: WO-02/48139 (2002-06-01), None
patent: WO-02/056013 (2002-07-01), None
patent: WO-02/080841 (2002-10-01), None
patent: WO-02/081469 (2002-10-01), None
patent: WO-02/096890 (2002-12-01), None
patent: WO-02/096916 (2002-12-01), None
patent: WO-02/096917 (2002-12-01), None
patent: WO-02/096918 (2002-12-01), None
patent: WO-02/102785 (2002-12-01), None
patent: WO-03/008395 (2003-01-01), None
patent: WO-03/022824 (2003-03-01), None
patent: WO-03/035073 (2003-05-01), None
patent: WO-03/035648 (2003-05-01), None
patent: WO-03/072575 (2003-09-01), None
patent: WO-03/072576 (2003-09-01), None
patent: WO 2004029066 (2004-04-01), None
Pae, A.N., et al., “Synthesis and In Vitro Activity of New Oxazolidinone Antibacterial Agents Having Substituted Isoxazoles,” Bioorganic & Medicinal Chemistry Letters, 9, 2679-2684, (1999).
Park, C.H., et al., “Antibacterials. Synthesis and Structure-Activity Studies of 3-Aryl-2-oxooxazolidines. 4. Multiply-Substituted Aryl Derivatives,” J. Med. Chem., 35, 1156-1165 (1992).
Gregory, W.A., et al., “Antibacterials. Synthesis and Structure-Activity Studies of 3-Aryl-2-oxooxazolidines. 2. The ‘A’ Group,” J. Med. Chem., 33, 2569-2578 (1990).
Skacani, I., et al., “The preparation and fungicidal activity of a series of 1-[(3-arylisoxazolin- or isoxazol-5-yl)methyl]-1H-1,2,4-triazoles,” Chem. Papers, 45(6), 807-815 (1991).
AstraZeneca AB
Grazier Nyeemah
Saeed Kamal A.
LandOfFree
Isoxazoline derivatives useful as antimicrobials does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoxazoline derivatives useful as antimicrobials, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoxazoline derivatives useful as antimicrobials will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3568965